Group B Streptococcal Testing During Pregnancy: Survey of Postpartum Women and Audit of Current Prenatal Screening Practices

Journal of Obstetrics and Gynaecology Canada

Volumn 27, Issue 11, 2005, Pages 1006-1012

  Youden, Laura ^a   Downing, Mark ^a   Halperin, Beth ^b,c   Scott, Heather ^b,c   Smith, Bruce ^a   Halperin, Scott A ^b,c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c IWK HEALTH CENTRE   (Canada)

Author keywords

Antibiotic prophylaxis; Attitudes, practice; Guidelines; Health knowledge; Medical audit; Streptococcus agalactiae

Indexed keywords

AMPICILLIN; CEFAZOLIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIUM CULTURE; CLINICAL PRACTICE; CONTROLLED STUDY; DOCUMENTATION; ETHNICITY; FEMALE; GROUP B STREPTOCOCCAL INFECTION; HEALTH BELIEF; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL ATTITUDE; PERINATAL CARE; PRACTICE GUIDELINE; PREGNANCY; PRENATAL CARE; PRENATAL SCREENING; PRIMARY HEALTH CARE; PUERPERIUM; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SAMPLER; TERTIARY HEALTH CARE; VERTICAL TRANSMISSION; ATTITUDE TO HEALTH; CANADA; INFORMATION PROCESSING; ISOLATION AND PURIFICATION; MASS SCREENING; METHODOLOGY; NEWBORN; PATIENT COMPLIANCE; PILOT STUDY; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; FEMALE; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFANT, NEWBORN; MASS SCREENING; NOVA SCOTIA; PATIENT COMPLIANCE; PILOT PROJECTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PRENATAL DIAGNOSIS; QUESTIONNAIRES; RISK FACTORS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 33646343476     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)30498-4     Document Type: Article

References (20)

1. Arisoy AS, Altinisi B, Tonger O, Kurotepe S, Ispani C Maternal carriage and antimicrobial resistance profile of group B streptococcus. Infection 2003, 31(4):244-246.
2. Taylor JK, Hall RW, Dupre AR The incidence of group B streptococcus in the vaginal tracts of pregnant women in central Alabama. Clin Lab Sci 2002, 5(l):16-17.
3. Joshi AK, Chen CI, Turnell RW Prevalence and significance of group B streptococcus on a large obstetric population. CMAJ 1987, 137(3):209-211.
4. Uhiara JE Group B streptococcal carriage among parturients and their neonates in Zarid, Nigeria. Afr J Med Med Sci 1983, 2(3):79-83.
5. Davies HD, Raj S, Adair C, Robinson J, McGeer A Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation. Pediatr Infect Dis J 2001, 20(9):879-884.
6. Luck S, Torny M, d'Agapeyeff K, Pitt A, Heath P, Breathnach A, et al. Estimated early-onset group B streptococcal neonatal disease. Lancet 2003, 361(9373):1953-1954.
7. Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention. MMWR Recomm Rep 1996;45(RR-7):1-24.
8. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Pediatrics 1997, 99(3):489-496. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection.
9. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A Prevention of perinatal group B streptococcal disease: Revised guidelines from the CDC. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002, 51(11):1-22.
10. Davies HD. Canadian Paediatric Society. Preventing group B streptococcal infections: New recommendations. Paed & Child Hlth 2002;7(6).
11. Schräg SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002, 347(4):233-239.
12. Reproductive Care Program of Nova Scotia. Guidelines for antenatal laboratory screening & testing. July 2003.
13. Benitz WE, Gould JB, Druzin ML Preventing early-onset group B streptococcal sepsis: strategy development using decision analysis. Pediatrics 1999, 103(6):e76.
14. Vergani P, Patane L, Colombo C, Borroni C, Giltri G, Ghidini A Impact of different prevention strategies on neonatal group B streptococcal disease. Am J Perinatol 2002, 19(6):341-348.
15. Davies HD, Adair CE, Schuchat A, Low DE, Sauve RS, McGeer A Physicians' prevention practices and incidence of neonatal group B streptococcal disease in 2 Canadian regions. CMAJ 2001, 164(4):479-485.
16. Schuchat A, Roome A, Zell ER, Linardos H, Zywicki S, O'Brien KL Integrated monitoring of a new group B streptococcal disease prevention program and other perinatal infections. Matern Child Health J 2002, 6(2):107-114.
17. Pinette MG, Wax JR, Blackstone J, Cartin A, McCrann DJ Culture-based group B streptococcal screening adherence to current guidelines. J Reprod Med 2003, 48(5):309-312.
18. Reid M. Consumer-oriented studies in relation to prenatal screening tests. Eur J Obstet Gynecol Reprod Biol 1988;(28 Suppl):79-92.
19. Darbyshire P, Collins C, McDonald HM, Hiller JE Taking antenatal group B Streptococcus seriously: women's experiences of screening and perceptions of risk. Birth 2003, 30(2):116-123.
20. Money DM, Dobson S SOCG clinical practice guidelines: The prevention of early-onset neonatal group B streptococcal disease. J Obstet Gynaecol Can 2004, 26(9):826-832.